AR063862A1 - Composiciones para la apariencia de la piel y metodos para su uso - Google Patents
Composiciones para la apariencia de la piel y metodos para su usoInfo
- Publication number
- AR063862A1 AR063862A1 ARP070105139A ARP070105139A AR063862A1 AR 063862 A1 AR063862 A1 AR 063862A1 AR P070105139 A ARP070105139 A AR P070105139A AR P070105139 A ARP070105139 A AR P070105139A AR 063862 A1 AR063862 A1 AR 063862A1
- Authority
- AR
- Argentina
- Prior art keywords
- skin
- probe
- sample
- skin sample
- compositions
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4737—C-reactive protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/20—Dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente se relaciona con composiciones y métodos para el tratamiento, prevención y mejora de la condición y apariencia estética de la piel, particularmente, el tratamiento, prevención, mejoramiento, reducción y/o eliminación de las líneas finas y/o las arrugas de la piel, donde las composiciones incluyen constituyentes naturales de plantas o sus equivalentes sintéticos, los cuales inhiben o disminuyen la expresión, producción o secreción de la proteína C-reactiva, reduciendo, inhibiendo o mejorando de ese modo las senales dermatológicas del envejecimiento. Las composiciones de la presente se pueden aplicar tópicamente a la piel, o se suministran por medios dirigidos al sitio que los requiera, en una cantidad efectiva para el mejoramiento de la condición y apariencia estética de la piel. Reivindicación 1: Una composición que comprende: (a) la cantidad de al menos un ingrediente activo, efectivo desde el punto de vista cosmético, dermatológico, farmacéutico o fisiológico, suficiente para inhibir o disminuir la expresión, producción o secreción de la proteína C-reactiva, y (b) un vehículo aceptable desde el punto de vista cosmético, dermatológico, farmacéutico o fisiológico, en el cual dicha composición mejora la condición y/o apariencia estética de una superficie biológica. Reivindicación 2: La composición de la reivindicación 1, en la cual el ingrediente activo se deriva de H. scandens, H. japonicus, H. lupullus y H. yunnanensis, cualesquiera combinaciones de los mismos o de sus equivalentes sintéticos. Reivindicación 24: Un método de detección de la inflación y envejecimiento de la piel asociado con la CRP, que comprende: (a) reacción a la muestra de piel con una sonda; y (b) detección de la presencia de la sonda, en el cual la sonda detecta la proteína C-reactiva y la detección de la sonda indica una inflamación asociada con la CRP y el riesgo de progresión asociado con la CRP de una piel que envejece. Reivindicación 25: Un método de monitorización de una muestra de piel, que comprende: (a) el tratamiento de una muestra de piel con una composición de prueba; (b) reacción de la muestra de piel tratada con una sonda; (c) reacción de una muestra de piel de control con una sonda; (d) comparación de la muestra de piel de control con la muestra de piel tratada para determinar la presencia de la sonda, donde la presencia de la sonda identifica la presencia de una proteína C-reactiva, monitorizando de ese modo el tratamiento de una muestra de piel.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/647,648 US7642062B2 (en) | 2006-12-29 | 2006-12-29 | Compositions and methods of their use for improving the condition and appearance of skin |
Publications (1)
Publication Number | Publication Date |
---|---|
AR063862A1 true AR063862A1 (es) | 2009-02-25 |
Family
ID=39584317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105139A AR063862A1 (es) | 2006-12-29 | 2007-11-20 | Composiciones para la apariencia de la piel y metodos para su uso |
Country Status (10)
Country | Link |
---|---|
US (2) | US7642062B2 (es) |
EP (1) | EP2117505A2 (es) |
JP (1) | JP2010514774A (es) |
CN (1) | CN101573101A (es) |
AR (1) | AR063862A1 (es) |
BR (1) | BRPI0718885A2 (es) |
CA (1) | CA2674226A1 (es) |
MX (1) | MX2009005066A (es) |
TW (1) | TW200826971A (es) |
WO (1) | WO2008082736A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2749552B1 (en) * | 2007-04-17 | 2015-11-18 | Codman & Shurtleff, Inc. | Curcumin-resveratrol hybrids |
US8383865B2 (en) * | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
US7745670B2 (en) * | 2008-06-27 | 2010-06-29 | Codman & Shurtleff, Inc. | Curcumin-Resveratrol hybrid molecule |
US7985776B2 (en) * | 2008-06-27 | 2011-07-26 | Codman & Shurtleff, Inc. | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease |
US7723515B1 (en) * | 2009-01-26 | 2010-05-25 | Codman & Shurtleff, Inc. | Methylene blue—curcumin analog for the treatment of alzheimer's disease |
US20100286585A1 (en) * | 2009-01-26 | 2010-11-11 | Codman & Shurtleff, Inc. | Shunt Delivery of Curcumin |
KR101223749B1 (ko) * | 2009-11-20 | 2013-01-17 | 재단법인 제주테크노파크 | 율초 또는 붉가시나무 잎 추출물을 이용한 아토피 피부염 개선제 조성물 |
CN106727054A (zh) * | 2010-06-30 | 2017-05-31 | 雅芳产品公司 | 用于刺激magp‑1以改善皮肤外观的组合物和方法 |
US8658227B2 (en) | 2011-03-02 | 2014-02-25 | Leslie Marie Radentz | Botanical formulation derived from birch bark |
KR101523812B1 (ko) * | 2012-03-07 | 2015-05-28 | 손원록 | 율초 추출물을 유효성분으로 함유하는 대사성 질환 예방 및 치료용 조성물 |
JP6823938B2 (ja) * | 2016-03-30 | 2021-02-03 | 株式会社アイビー化粧品 | 皮膚外用剤 |
KR102194073B1 (ko) * | 2018-12-06 | 2020-12-22 | 농업회사법인제주생물자원(주) | 하귤 오일을 포함하는 피부 노화 억제 및 피부 보습용 기능성 화장료 조성물 |
FR3097559B1 (fr) * | 2019-06-24 | 2021-06-25 | Oreal | Méthode de diagnostic de dégradations esthétiques de la peau |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US596842A (en) * | 1898-01-04 | Waterproof material | ||
US4379454A (en) * | 1981-02-17 | 1983-04-12 | Alza Corporation | Dosage for coadministering drug and percutaneous absorption enhancer |
US4820724A (en) * | 1986-03-31 | 1989-04-11 | University Of Southern California | Dual phase solvent carrier system |
US5223262A (en) * | 1989-02-23 | 1993-06-29 | University Of Utah | Transdermal delivery system utilizing one way membranes |
US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
US5580575A (en) * | 1989-12-22 | 1996-12-03 | Imarx Pharmaceutical Corp. | Therapeutic drug delivery systems |
US5146846A (en) * | 1990-05-01 | 1992-09-15 | F. H. Maloney Company | Roller assembly for grain shellers |
US5834513A (en) * | 1996-04-25 | 1998-11-10 | Avon Products, Inc. | Oxa diacids and related compounds for treating skin conditions |
US5847003A (en) * | 1996-06-04 | 1998-12-08 | Avon Products, Inc. | Oxa acids and related compounds for treating skin conditions |
JPH1072336A (ja) * | 1996-06-28 | 1998-03-17 | Kao Corp | コラーゲンゲル収縮促進剤 |
JP4915714B2 (ja) * | 1996-06-28 | 2012-04-11 | 花王株式会社 | コラーゲンゲル収縮促進剤 |
JPH1036279A (ja) * | 1996-07-18 | 1998-02-10 | Ichimaru Pharcos Co Ltd | 植物抽出物含有線維芽細胞増殖促進剤 |
KR100481107B1 (ko) * | 1996-09-30 | 2005-05-16 | 가부시키가이샤 시세이도 | 산화규소분체및그제조방법,그를이용한화장료,미셀유지분체,향료유지분체 |
US6726933B2 (en) * | 1996-09-30 | 2004-04-27 | Shiseido Co., Ltd. | Rod-shaped mesoporous powder, humectant adsorbing powder, and cosmetic preparation using the same |
JP3436037B2 (ja) * | 1997-01-10 | 2003-08-11 | 株式会社豊田中央研究所 | バルク状シリカ多孔体の製造方法 |
JPH11246336A (ja) * | 1998-02-27 | 1999-09-14 | Ichimaru Pharcos Co Ltd | 活性酸素消去剤及び美肌化粧料組成物 |
JPH11246387A (ja) * | 1998-03-03 | 1999-09-14 | Shiseido Co Ltd | 抗老化剤 |
US6096327A (en) * | 1998-11-05 | 2000-08-01 | Protease Sciences Inc. | Cosmetic compositions containing human type serine protease inhibitors for revitalizing the skin |
JP2000247830A (ja) * | 1999-02-26 | 2000-09-12 | Nagase & Co Ltd | エラスターゼ阻害剤 |
US6056545A (en) * | 1999-04-20 | 2000-05-02 | Lemchen; Marc. S. | Mesoporous metal for orthodontic appliances |
JP4070065B2 (ja) * | 1999-07-15 | 2008-04-02 | 株式会社資生堂 | 肌あれ防止・改善用皮膚外用剤 |
US7736661B1 (en) | 2000-03-07 | 2010-06-15 | Avon Products, Inc | Method of treating skin conditions |
WO2001068804A2 (en) * | 2000-03-10 | 2001-09-20 | Lifespan Biosciences, Inc. | Nucleic acid sequences associated with aging, particularly skin aging |
JP2003536075A (ja) * | 2000-06-08 | 2003-12-02 | ボード・オブ・リージェンツ,ザ・ユニヴァーシティ・オヴ・テキサス・システム | C反応性タンパク質誘導性炎症のインヒビター |
DE10132953A1 (de) * | 2001-07-06 | 2003-01-16 | Beiersdorf Ag | Verwendung von Hopfen-bzw. Hopfen-Malz-Extrakten in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe gegen und Behandlung von degenerativen Hauterscheinungen |
CA2474974A1 (en) * | 2002-02-07 | 2003-08-14 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
ITMI20020632A1 (it) | 2002-03-27 | 2003-09-29 | Indena Spa | Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene |
US20040213996A1 (en) * | 2002-04-30 | 2004-10-28 | National Institute Of Advanced Industrial Science And Technology | Mesoporous inorganic materials having controlled-release on-off control function, production method thereof and method using same |
US6902806B2 (en) * | 2002-04-30 | 2005-06-07 | National Institute Of Advanced Science And Technology | Mesoporous silica having controlled-release on-off control function, production method thereof and method using same |
ITMI20021691A1 (it) | 2002-07-30 | 2004-01-30 | Indena Spa | Estratti di echinacea angustifolia |
ITMI20021692A1 (it) | 2002-07-30 | 2002-10-29 | Indena Spa | Polisaccaride di echinacea angustifolia. |
ITMI20032286A1 (it) * | 2003-11-24 | 2005-05-25 | Indena Spa | Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne |
US7183057B2 (en) * | 2004-03-31 | 2007-02-27 | Dermtech International | Tape stripping methods for analysis of skin disease and pathological skin state |
US20050260265A1 (en) * | 2004-05-20 | 2005-11-24 | Wyrsta Michael D | Mesostructured silica/block copolymer monoliths as a controlled release device and methods of manufacture |
US7618662B2 (en) * | 2004-12-22 | 2009-11-17 | Avon Products, Inc | Use of natural plant extracts in cosmetic compositions |
JP2006327966A (ja) * | 2005-05-25 | 2006-12-07 | Pola Chem Ind Inc | 皮膚外用剤とその適用 |
JP2006327967A (ja) * | 2005-05-25 | 2006-12-07 | Pola Chem Ind Inc | フラボノイドを含有する皮膚外用剤 |
-
2006
- 2006-12-29 US US11/647,648 patent/US7642062B2/en not_active Expired - Fee Related
-
2007
- 2007-10-10 MX MX2009005066A patent/MX2009005066A/es active IP Right Grant
- 2007-10-10 WO PCT/US2007/080940 patent/WO2008082736A2/en active Application Filing
- 2007-10-10 CN CNA2007800473821A patent/CN101573101A/zh active Pending
- 2007-10-10 BR BRPI0718885-4A2A patent/BRPI0718885A2/pt not_active IP Right Cessation
- 2007-10-10 EP EP07844082A patent/EP2117505A2/en not_active Withdrawn
- 2007-10-10 JP JP2009544129A patent/JP2010514774A/ja active Pending
- 2007-10-10 CA CA002674226A patent/CA2674226A1/en not_active Abandoned
- 2007-10-25 TW TW096140091A patent/TW200826971A/zh unknown
- 2007-11-20 AR ARP070105139A patent/AR063862A1/es unknown
-
2009
- 2009-11-18 US US12/621,027 patent/US20100062086A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2674226A1 (en) | 2008-07-10 |
CN101573101A (zh) | 2009-11-04 |
EP2117505A2 (en) | 2009-11-18 |
BRPI0718885A2 (pt) | 2014-02-18 |
US20100062086A1 (en) | 2010-03-11 |
WO2008082736A3 (en) | 2008-10-09 |
WO2008082736A2 (en) | 2008-07-10 |
TW200826971A (en) | 2008-07-01 |
MX2009005066A (es) | 2009-05-25 |
US7642062B2 (en) | 2010-01-05 |
JP2010514774A (ja) | 2010-05-06 |
US20080160109A1 (en) | 2008-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR063862A1 (es) | Composiciones para la apariencia de la piel y metodos para su uso | |
Shivhare et al. | Wound healing potential of methanolic extract of Trichosanthes dioica Roxb (fruits) in rats | |
BR112015019440A8 (pt) | curativo regulável, kit, uso e método para fortalecimento da pele | |
BRPI0816214B8 (pt) | uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas | |
DOP2011000045A (es) | Anticuerpos monoclonales contra el inhibidor de la via del factor tisular (tfpi) | |
CO6761350A2 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis | |
FR2889057B1 (fr) | Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches | |
SV2009003098A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
San Cheang et al. | Menthol relaxes rat aortae, mesenteric and coronary arteries by inhibiting calcium influx | |
AR081789A1 (es) | Composiciones y metodos para estimular magp-1 y mejorar la apariencia de la piel | |
AR097599A1 (es) | Una composición que comprende extracto de guaçatonga y aroeira, su uso y un método para la prevención y/o tratamiento de señales causadas por el envejecimiento de la piel | |
BR112016008010A2 (pt) | uso de moléculas de ligação de semaforina-4d para tratamento de aterosclerose | |
DOP2007000043A (es) | Derivados de cromanol sustituidos y su uso | |
WO2008033495A3 (en) | Method for detecting and treating skin disorders | |
WO2012122082A3 (en) | Methods for activating caspase-14 expression in human skin | |
FR2937972B1 (fr) | Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique | |
AR074450A1 (es) | Metodos y usos que implican la proteina 1 de union a hemo | |
FR2977797B1 (fr) | Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures | |
JPWO2011040495A1 (ja) | ヘパラナーゼ活性阻害剤並びにそれを含有するしわ改善剤及び医薬組成物 | |
BRPI1008103A2 (pt) | " peptídeo de cadeia curta isolado, composição farmacêutica, compostos, método de evitar ou tratar doenças, medicamento para tratar/ reduzir condições médicas e uso dos compostos " | |
Chen et al. | Endothelium-dependent and-independent relaxation of rat aorta induced by extract of Schizophyllum commune | |
CN105101984B (zh) | 丙氨酸-谷氨酰胺、透明质酸和燕麦提取物的协同组合以及其在用于愈合伤口和修复皮肤损伤的组合物中的用途 | |
EA200602002A1 (ru) | Применение спинозинов для заживления ран | |
EP2327393A3 (de) | Verwendung von Zingeron gegen Altershaut | |
Al-Tarifi et al. | Inhibitory effects of astaxanthin on lps-induced raw 264.7 inflammation and breast cancer mcf-7 cell lines proliferation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |